D3 Bio, a global clinical-stage biotechnology company focused on the discovery and development of innovative oncology therapeutics, announced the completion of a $108 million Series B financing round.

RMAT designation indicates that SENTI-202 has the potential to address unmet medical needs for patients with Relapsed/Refractory (R/R) Acute ...

ASH 2025 oral presentation on SENTI-202 in 20 Relapsed/Refractory Acute Myeloid Leukemia (R/R AML) patients (18 response evaluable) shows high efficacy: 50% ORR and 42% CR/CRh (100% of CRs and 83% of ...

"I’m just going to believe that was the name of half the girls in the background in every season," the poster told Newsweek.

Class 10 and 12 theory exams start on February 17 with English and cover major subjects like Mathematics, Physics, and ...

One is a seasoned sports and entertainment executive. The other has cut a long trail of tech involvement. Together, they now ...

Formerra will distribute Techmer PM color masterbatches, high-performance additives, and pre-colored compounds across the U.S., Canada, and Mexico. ROMEOVILLE, ILLINOIS / ACCESS Newswire / December 9, ...

Fibrocor Therapeutics strengthens its clinical strategy with the appointment of four world-leading nephrology and genetics experts to its Clinical Advisory Board (CAB), reinforcing its scientific ...

Y’all-itics takes a closer look at how Alpha Schools truly work, and what parents need to know before considering this option ...

Parkinson's disease represents a $6-8 billion market today, projected to exceed $13 billion by the 2030s, driven by rising ...

Clinician Perspectives on Holistic Management of PKP2-Associated Arrhythmogenic Cardiomyopathy December 9, 2025 3:00 ...